Akouos, Inc.
Clinical trials sponsored by Akouos, Inc., explained in plain language.
-
Gene therapy could restore hearing in children born deaf
Disease control Recruiting nowThis study tests a gene therapy for people with severe hearing loss caused by otoferlin gene mutations. The treatment delivers a working copy of the gene into the inner ear during a single surgery. Up to 22 participants of any age will be enrolled to check safety and whether hear…
Phase: PHASE1, PHASE2 • Sponsor: Akouos, Inc. • Aim: Disease control
Last updated May 26, 2026 08:44 UTC
-
New gene therapy aims to shrink ear tumors without surgery
Disease control Recruiting nowThis early-stage trial tests a gene therapy (AAVAnc80-antiVEGF) given as a single injection into the inner ear for people with a growing vestibular schwannoma (a non-cancerous tumor on the hearing nerve) and profound hearing loss in that ear. The study will check safety and wheth…
Phase: PHASE1, PHASE2 • Sponsor: Akouos, Inc. • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
Scientists observe rare genetic hearing loss over time
Knowledge-focused Recruiting nowThis study follows up to 150 people with hearing loss caused by changes in the otoferlin gene. Researchers will measure hearing using tests like auditory brainstem response (ABR) and otoacoustic emissions (OAE) over time. The goal is to better understand how this type of hearing …
Sponsor: Akouos, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:43 UTC